Ablynx

• locale

  Belgium

• market

  PRIVATE

• industry

  Biotechnology

• website

  www.ablynx.com

Ablynx develops NANOBODY® technology, which enables the creation of new therapeutics and the refinement of existing treatments. The technology utilizes miniature, engineered antibodies derived from camelids, allowing for the design of multi-targeting therapies.